Too many tests are bad: A new study found that a large number of tests for prostate cancer are dangerous and does not save lives, but put men in danger

Routine cancer detection tests have become infamous for giving false positive information, leading to unnecessary diagnosis of benign carcinoma

False diagnoses of prostate cancer are common and emotionally disrupted by patients.

When someone says they have cancer, they are often affected by anxiety. False diagnosis also leads to an aggressive, costly and many times deadly treatment protocol consisting of chemotherapy, radiation, and surgery.

Significant complications may occur, including incontinence and impotence. Those who survive an unnecessary protocol for treatment are often said to have cured cancer, which means unnecessary test protocols and treatment processes are effective, and in fact they are just expensive scammers.

Regular searches for prostate cancer in men over the age of fifty can also miss more serious cancers, leaving patients a false sense of security about their own health.

Too many tests are an emotional hazard, whether they are burdening patients with false diagnosis or leading them to a path where nothing is done to improve their health even when there are real conditions in which cancer develops in their body.

A study conducted by Cancer Research UK examined the results of all tests in men over fifty who underwent prostate specific antigen (PSA) tests and compared results in men who were not subjected to a prostate test.

The mortality rate for regularly tested patients was no different from the mortality of those who were not at all prostate testing at all!

Researchers argue that testing actually puts the risk and additional pressure on people. They warn that people without symptoms of the disease who undergo a single test can only get a false diagnosis because testing reveals tumors and which are not harmful. They also warned that prostate testing can completely miss the tumors that could become fatal.

"An excessive diagnosis of prostate cancer probably kills thousands of men every year from unnecessary but toxic therapeutic interventions that damage the health of the heart, brain and kidneys," a noted scientist warns.

"The victim of overly diagnosed stems from the lack of any real economic incentive for the cancer industry that should follow accuracy standards or quality control when it comes to diagnosing cancer" - adds.

"In fact, looking at economic interests, the cancer clinic should provide as many false positive results as possible and then use false test results to terrorize patients through various risky cancer treatment treatments that are financially beneficial to the same clinics that carry out illegal diagnoses," he said.

You will never know if the diagnosis is correct, unless you insist on another doctor's opinion or other testing, but this will relieve the patient emotionally and physically, yet it is worth trying.

PSA tests for prostate cancer do not save lives, but generate huge incomes for clinics that "cure cancer"
The researchers studied 400,000 British men aged between 50 and 69 over a ten-year period.

The control group, which was 219,439 men, was not examined and had 7,853 cases of prostate cancer (3.6%). 189,386 men who were invited to the PSA test were diagnosed with cancer much more often (4.3%).

In monitoring, the same percentage of men died of prostate cancer, suggesting that the PSA test does not save lives and only leads to dangerous over-the-counter treatment.

Leading author of the study, Professor Richard Martin, a research scientist at Cancer Research at the University of Bristol, said: "We found that PSA tests on men without any prostate cancer symptoms are not saving lives after an average follow-up of 10 years."

"The results point to a variety of questions that pull the PSA test - causing unnecessary anxiety and treatment by diagnosing prostate cancer in men who have never been affected by the symptoms and where no prostate cancer has been detected," said Professor Martin.

# Conducting a PSA test to determine if prostate cancer is like attempting an operation with a blunt instrument. The PSA test is not accurate and does not differentiate the types of carcinoma that are aggressive and those who are not.

The PSA test uses a blood test to monitor the protein that produces a gland if there is cancer. If the test detects a high level of protein, the test is positive for cancer, although there is no solid evidence of an aggressive tumor. The test is vague and dependent on an unreliable biomarker.

Researchers are calling for a better way to detect prostate cancer, but new research may be on the wrong path.

Current research is developing genetic tests to identify patients who might be more likely to develop prostate cancer. This method will also lead many people to unnecessary treatments, all because of the fear that their genetics will cause cancer in the future. (NaturalNews)

• 1 Apr, 2018
• 1444 views